China BCT Pharmacy Group Inc. Stock Analysis CNBI

China BCT Pharmacy Group, Inc. engages in the distribution, retail and manufacture of pharmaceuticals. The company is headquartered in Liuzhou, Guangxi and currently employs 1,677 full-time employees. The company went IPO on 2010-03-03. The firm mainly operates it business through three segments. The Pharmaceutical Distribution segment is engaged in the purchasing pharmaceutical products from suppliers and then distributing them to wholesale customers, including hospitals, retail drug stores, other pharmaceutical wholesalers, clinics, medical centers, and individuals. The Retail Pharmacy segment is engaged in the operation of retail drug stores under the registered name Baicaotang. The Manufacturing segment is engaged in the production and sales of pharmaceutical products under the registered name Asio including traditional anti-inflammatory and antibacterial drugs, cancer treatment drugs, cardio-vascular disease drugs and hepatitis drugs. The firm mainly conducts its business in the domestic market.